STATE OF TEXAS; AMERICAN ASSOCIATION OF PRO-LIFE OBSTETRICIANS & GYNECOLOGISTS; CHRISTIAN MEDICAL & DENTAL ASSOCIATIONS, Plaintiffs-Appellees, versus XAVIER BECERRA; UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES; CENTERS FOR MEDICARE AND MEDICAID SERVICES; KAREN L. TRITZ; DAVID R. WRIGHT, Defendants-Appellants.
No. 23-10246
United States Court of Appeals for the Fifth Circuit
January 2, 2024
Kurt D. ENGELHARDT, Circuit Judge
Kurt D. ENGELHARDT, Circuit Judge:
The Emergency Medical Treatment and Active Labor Act of 1986 (“EMTALA”),
The State of Texas, along with two medical associations with members located in Texas (“Texas plaintiffs”), sued the Department of Health and Human Services (“HHS”), HHS Secretary Xavier Becerra, the Centers for Medicare and Medicaid Services (“CMS”), the Director of the Survey and Operations Group for CMS, and the Director of the Quality Safety and Oversight Group for CMS (collectively “HHS”), challenging HHS‘s guidance on EMTALA‘s requirement that physicians must provide an abortion when that care is the necessary stabilizing treatment for an emergency medical condition. The Texas plaintiffs alleged that the guidance mandates providers to perform elective abortions in excess of HHS‘s authority and contrary to state law and sought to enjoin its enforcement. The district court enjoined the guidance‘s interpretation of EMTALA within Texas or against any member of a plaintiff organization. HHS appealed. For the following reasons, we AFFIRM.
I.
A.
In 1986, Congress enacted EMTALA to ensure public access to emergency services regardless of a patient‘s ability to pay.
There are three stages to EMTALA: (1) screening; (2) stabilizing; and (3) transfer. When an individual presents to a Medicare-participating emergency department
(i) placing the health of the individual (or, with respect to a pregnant woman, the health of the woman or her unborn child) in serious jeopardy,
(ii) serious impairment to bodily functions, or
(iii) serious dysfunction of any bodily organ or part.
(i) that there is inadequate time to effect a safe transfer to another hospital before delivery, or
(ii) that transfer may pose a threat to the health or safety of the woman or the unborn child.
If the hospital determines that a patient has an “emergency medical condition,” the hospital must offer patients “[n]ecessary stabilizing treatment[s]” or a “transfer of the individual to another medical facility.”
B.
On June 24, 2022, the United States Supreme Court issued its decision in Dobbs v. Jackson Women‘s Health Organization, 142 S. Ct. 2228, 2279 (2022), holding “that the Constitution does not confer a right to abortion” and that “the authority to regulate abortion must be returned to the people and their elected representatives.” In the wake of Dobbs, so-called “trigger laws” sprung into effect, meaning laws that were enacted in anticipation of abortion‘s return to state control automatically went into effect. The Texas Human Life Protection Act (“HLPA”) is such a law. Dobbs triggered HLPA‘s 30-day clock and the law went into effect on August 25, 2022. The HLPA prohibits abortions unless the pregnancy “places the female at risk of death or poses a serious risk of substantial impairment of a major bodily function.”
Two weeks after Dobbs, on July 11, 2022, CMS issued “Reinforcement of EMTALA Obligations specific to Patients who are Pregnant or are Experiencing Pregnancy Loss” (“the Guidance”)3 and a supporting letter (“the Letter”)4 to state healthcare-agency directors, reminding hospitals of their existing and continuing obligations under EMTALA in light of new state laws prohibiting or restricting access to abortion. Guidance at 1-2. The Guidance is at the forefront of this appeal. Most notably, the Guidance states:
If a physician believes that a pregnant patient presenting at an emergency department is experiencing an emergency medical condition as defined by EMTALA, and that abortion is the stabilizing treatment necessary to resolve that condition, the physician must provide that treatment. When a state law prohibits abortion and does not include an exception for the life of the pregnant person—or draws the exception more narrowly than EMTALA‘s emergency medical condition definition—that state law is preempted.
Id. at 1 (emphasis in original). According to the Guidance, “[e]mergency medical conditions involving pregnant patients may include, but are not limited to, ectopic pregnancy, complications of pregnancy loss, or emergent hypertensive disorders, such as preeclampsia with severe features.” Id. The Guidance notes that “[t]he course of treatment necessary to stabilize such emergency medical conditions is also under the purview of the physician or other qualified medical personnel.” Id. at 4. The Guidance‘s enforcement provision warns hospitals of penalties for physicians who refuse to provide “necessary stabilizing care for an individual presenting with an emergency medical condition that requires such stabilizing treatment, or an appropriate transfer.” Id. at 5. It also informs that “[a]ny state actions against a physician who provides an abortion in order to stabilize an emergency medical condition in a pregnant individual presenting to the hospital would be preempted by the federal EMTALA statute due to the direct conflict with the ‘stabilized’ provision of the statute.” Id. Endorsed by HHS Secretary Becerra, the Letter reenforces the same message. See Letter at 1–2.
C.
On July 14, 2022, Texas filed a complaint in the Northern District of Texas challenging the Guidance pursuant to, inter alia, the Administrative Procedure Act (“APA”) and Medicare Act. The crux of the complaint is that EMTALA does not authorize the federal government to compel healthcare providers to perform abortions, and thus, the Guidance is unlawful and must be set aside. Two weeks later, on July 28, 2022, Texas amended the complaint, adding as co-plaintiffs the American Association of Pro-Life Obstetricians & Gynecologists (“AAPLOG”) and Christian Medical & Dental Associations (“CMDA”).5
Thereafter, on August 3, 2022, the Texas plaintiffs moved for a temporary restraining order and a preliminary injunction. After a hearing on the matter, the district court issued an order granting a preliminary injunction and simultaneously denying HHS‘s motion to dismiss, finding the Texas plaintiffs had requisite standing and thus the district court did not lack subject matter jurisdiction. Texas v. Becerra, 623 F. Supp. 3d 696 (N.D. Tex. 2022). As an initial matter, and addressing the claims raised in the Rule 12(b)(1) motion, the district court concluded that the Texas plaintiffs had Article III standing to raise their claims. Id. at 709–19. The district court also determined that the Guidance constituted a final agency action. Id. at 720–24. As determined by the district court, the Guidance is neither subject to further agency review nor a mere intermediate step in a multi-stage administrative process. Id. at 720–21. Rather, it binds
On September 1, 2022, HHS moved to clarify the district court‘s injunction. According to HHS, it was unclear whether they could continue to enforce the Guidance‘s interpretation of EMTALA in Texas and against the plaintiffs when an abortion would be permitted under state law. HHS filed its first notice of appeal before the district court ruled on the motion.7 Determining it had jurisdiction to decide the motion to clarify, the district court denied HHS‘s motion. Texas v. Becerra, No. 5:22-CV-185-H, 2022 WL 18034483, at *1–3 (N.D. Tex. Nov. 15, 2022).
On December 20, 2022, the district court entered a partial final judgment, converting the preliminary injunction into a permanent injunction. The parties then filed an unopposed motion to correct judgment under
(1) The defendants may not enforce the Guidance and Letter‘s interpretation that Texas abortion laws are preempted by EMTALA; and
(2) The defendants may not enforce the Guidance and Letter‘s interpretation of EMTALA—both as to when an abortion is required and EMTALA‘s effect on state laws governing abortion—within the State of Texas or against AAPLOG‘s members and CMDA‘s members.
Id. HHS moved to stay the first notice of appeal, and later, dismissed that appeal. Texas v. Becerra, No. 22-11037, 2023 WL 2366605 (5th Cir. Jan. 26, 2023). This appeal of the amended judgment followed.
II.
“We review the trial court‘s granting . . . of [a] permanent injunction for abuse of discretion.” Peaches Ent. Corp. v. Ent. Repertoire Assocs., Inc., 62 F.3d 690, 693 (5th Cir. 1995) (citation omitted). We likewise review de novo the scope of an injunction. Texas v. Equal Emp. Opportunity Comm‘n, 933 F.3d 433, 450 (5th Cir. 2019) (citation omitted) [hereinafter EEOC]. Determinations on jurisdiction are reviewed de novo. Id. at 441 (footnote omitted).
III.
HHS does not raise standing on appeal. Pertinent to the question of jurisdiction on appeal, however, is (A.) whether the Guidance is a final agency action subject to the court‘s review.8 The remaining issues on appeal include (B.) whether the Guidance is consistent with EMTALA, (C.) whether the district court erred in concluding that the Guidance was required to undergo notice and comment under the Medicare Act, and (D.) whether the injunction is overbroad. Each issue will be analyzed in turn.
A.
The APA provides for judicial review of a “final agency action.”
HHS does not raise the first prong of the Bennett-inquiry. “Reviewability vel non of the Guidance thus turns on the second Bennett prong—whether ‘rights or obligations have been determined’ by it, or whether ‘legal consequences will flow’ from it.” EEOC, 933 F.3d at 441 (quoting Bennett, 520 U.S. at 178).
1.
Courts have consistently held that “an agency‘s guidance documents binding it and its staff to a legal position produce legal consequences or determine rights and obligations, thus meeting the second prong of Bennett.” EEOC, 933 F.3d at 441. “Whether an action binds the agency is evident ‘if it either appears on its face to be binding[] or is applied by the agency in a way that indicates it is binding.‘” Id. (alteration in original) (quoting Texas v. United States, 809 F.3d 134, 171 (5th Cir. 2015)); see also Ciba-Geigy Corp. v. U.S. Env‘t Prot. Agency, 801 F.2d 430, 436 (D.C. Cir. 1986) (holding that an action is final once the agency makes clear that it “expects regulated entities to alter their primary conduct to conform to [the agency‘s] position”). The governing case on the matter is Texas v. Equal Employment Opportunity Commission, 933 F.3d 433 (5th Cir. 2019). EEOC involved the Equal Employment Opportunity Commission‘s (“EEOC”) enforcement guidance that claimed blanket bans on hiring individuals with criminal records were violations of Title VII. Id. at 437-38. The court held that the guidance bound the EEOC to a specific legal position to such a degree that noncompliance with the guidance naturally risked legal consequences for employers. Id. at 446. EEOC directs courts to determine whether agency action binds the agency by looking for (1) mandatory language, (2) actions that restrict the agency‘s discretion to adopt a different view of the law, and (3) the creation of safe harbors from legal consequences. Id. at 441–43. In some cases, “‘the mandatory language of a
The district court found the Guidance contains all three. Texas, 623 F. Supp. 3d at 721–24. The Texas plaintiffs point to mandatory language throughout the Guidance for its binding effect, including the title and body of the text.
In this case, the mandatory language of the Guidance renders it binding. The title itself imposes “obligations.” Guidance at 1. The Guidance states that hospitals and physicians “must” provide an abortion as a stabilizing treatment “irrespective of any state laws or mandates.” Id. at 1, 4-5. It is a part of a “physician‘s professional and legal duty” to provide such treatment to a patient who presents under EMTALA. Id. at 1. The Guidance further states that physicians cannot be shielded from liability for “erroneously complying with state laws that prohibit services such as abortion or transfer of a patient for an abortion when the original hospital does not have the capacity to provide such services.” Id. at 4. Moreover, the Guidance threatens fines and loss of federal funding for noncompliance. Id. at 5. The Letter repeats the same message as the Guidance. Letter at 1-2. The Letter also warns that the enforcement of EMTALA is a complaint driven process and directs that violations of EMTALA should be initiated by a complaint. Id. at 2. The Letter states that violations of EMTALA may lead to civil penalties, including a physician‘s exclusion from “the Medicare and State health care programs.” Id. The language as to how EMTALA will be enforced effectively withdraws the agency‘s discretion “to adopt a different view of the law.” EEOC, 933 F.3d at 442. Private parties can also rely on the Guidance as a norm or safe harbor to avoid liability. Guidance at 5–6; see also EEOC, 933 F.3d at 443-44 (“The Guidance is ‘binding as a practical matter’ because ‘private parties can rely on it as a norm or safe harbor by which to shape their actions.‘” (quoting Cohen v. United States, 578 F.3d 1, 9 (D.C. Cir. 2009))); Gen. Elec., 290 F.3d at 383 (“private parties can rely on it as a norm or safe harbor by which to shape their actions”).
HHS‘s reliance on Luminant Generation Co., L.L.C. v. U.S. Environmental Protection Agency, 757 F.3d 439 (5th Cir. 2014), for the notion that the Guidance has no independent legal force, is distinguishable from EEOC. Luminant involved notice of violations sent by the Environmental Protection Agency (“EPA”) informing the plaintiff power plant of violations under the Clean Air Act. Id. at 440. It was the Clean Air Act—not the EPA‘s notice of violations to the plaintiff power plant—that set forth the plaintiff‘s rights and obligations. Id. at 442. EEOC distinguished its guidance from the notice of violations in Luminant, holding that “the EPA notices merely expressed the agency‘s opinion about the legality of the plaintiff‘s conduct; it did not . . . commit the administrative agency to a specific course of action should the plaintiff fail to comply with the agency‘s view.” EEOC, 933 F.3d at 445 (citation and quotation marks omitted). The key, according to EEOC, is that the guidance “dictates how EEOC must assess claims of Title VII disparate-impact liability targeting employers with felon-hiring policies. The [g]uidance does not merely comment on a single employer‘s practices; it tells EEOC staff and all employers what sort of policy is unlawful.” Id.
2.
Under the second Bennett prong, agency action is not final if it “merely restate[s]” a statutory requirement or “merely reiterate[s] what has already been established.” Nat‘l Pork Prods. Council v. U.S. Env‘t Prot. Agency, 635 F.3d 738, 756 (5th Cir. 2011) (citations omitted). To constitute a final agency action, “rights, obligations, or legal consequences” created by a challenged action “must be new.” State v. Rettig, 987 F.3d 518, 529 (5th Cir. 2021) (citations omitted).
HHS argues that the Guidance is not “new.” In support, HHS submits two prior guidance documents: (1) a September 2021 guidance issued by CMS (“CMS guidance”);9 and a (2) September 2021 guidance issued by
HHS‘s Office for Civil Rights (“OCR”) (“OCR guidance”).10 These documents hardly qualify the Guidance in this case as “not new.” First, the September 2021 guidance by CMS does not mention abortion. This document directs hospitals to provide stabilizing treatment for persons who present to the emergency department, including pregnant women. CMS guidance at 1. So does EMTALA. See
Second, the September 2021 OCR guidance discusses the nondiscrimination protections under the Church Amendments,
The Texas plaintiffs claim that the Guidance is “new” for good reasons. HHS even admitted before the district court at the hearing on the preliminary injunction that it “hasn‘t issued a [G]uidance document specific like this one . . . because there wasn‘t a need for it. Everybody understood that this is what was required.” Tr. of Preliminary Injunction Hearing at 125. At oral argument, HHS sought to clarify that, while there are new factual circumstances, the obligations on hospitals remain the same regarding abortion. Oral Argument Recording at 2:52–3:19; 13:15-25; 13:49–56. We disagree with HHS. The new ingredient here is Dobbs, which caused a sea change in the law. Put simply, the Guidance sets out HHS‘s legal position—for the first time—regarding how EMTALA operates post-Dobbs. The Guidance is new policy; it does not “merely restate” EMTALA‘s requirements. Legal consequences flow from the Guidance, and it determines rights and obligations. The Guidance therefore constitutes final agency action.
B.
The APA requires courts to “hold unlawful and set aside agency action” that is “in excess of statutory jurisdiction, authority, or limitations, or short of statutory right.”
1.
Under EMTALA, if an “individual” is determined to be experiencing an “emergency medical condition,” see
Considering the statute as a whole, the Medicare Act states that “[n]othing in this subchapter shall be construed to authorize any Federal officer or employee to exercise any supervision or control over the practice of medicine or the manner in which medical services are provided.”
EMTALA does not specify stabilizing treatments in general, except one: delivery of the unborn child and the placenta.
The Texas plaintiffs’ argument that medical treatment is historically subject to police power of the States, not to be superseded
of Univ. of Va., 95 F.3d 349, 351 (4th Cir. 1996) (“Once EMTALA has met that purpose of ensuring that a hospital undertakes stabilizing treatment for a patient who arrives with an emergency condition, the patient‘s care becomes the legal responsibility of the hospital and the treating physicians.”); Eberhardt v. City of Los Angeles, 62 F.3d 1253, 1258 (9th Cir. 1995). And circuits recognize that state law, not EMTALA, governs medical malpractice. See, e.g., Marshall, 134 F.3d at 322–23; Eberhardt, 62 F.3d at 1258; Baber v. Hosp. Corp. of Am., 977 F.2d 872, 879–80 (4th Cir. 1992); Gatewood v. Washington Healthcare Corp., 933 F.2d 1037, 1039 (D.C. Cir. 1991).
In sum, EMTALA does not govern the practice of medicine. This is reflected in its purpose, see
2.
Most notably, the district court considered EMTALA‘s preemptive effects. EMTALA states: “The provisions of this section do not preempt any State or local law requirement, except to the extent that the requirement directly conflicts with a requirement of this section.”
First, Texas‘s HLPA law does not directly conflict with EMTALA. EMTALA imposes obligations on physicians with respect to both the pregnant woman and her unborn child. See
EMTALA refers to patients as “individuals” throughout. See generally
Congress specifically chose to define an emergency medical condition as a medical condition that places “the health of the individual (or, with respect to a pregnant woman, the health of the woman or her unborn child) in serious jeopardy.”
Finally, HHS claims that EMTALA mandates the pregnant woman to resolve
The question before the court is whether EMTALA, according to HHS‘s Guidance, mandates physicians to provide abortions when that is the necessary stabilizing treatment for an emergency medical condition. It does not. We therefore decline to expand the scope of EMTALA.
C.
Under the Medicare Act, an agency is required to conduct notice-and-comment rulemaking when promulgating any “rule, requirement, or other statement of policy . . . that establishes or changes a substantive legal standard governing . . . the payment for services” or “the eligibility of individuals, entities, or organizations to . . . receive services or benefits.”
The Guidance, at a minimum, falls under Azar‘s definition of a “statement of policy” because it lets the public know of HHS‘s “adjudicatory approach” concerning the application of EMTALA with respect to abortion and state abortion laws. The Texas plaintiffs list out a few obvious reasons, including the civil monetary penalties physicians and hospitals face if they do not provide abortions in various circumstances. Guidance at 5. According to the Guidance, “HHS [Office of the Inspector General] may also exclude physicians from participation in Medicare and State health care programs. CMS may also penalize a hospital by terminating its provider agreement.” Id. The Guidance also provides safe harbors for physicians, including “as a defense to a state enforcement action, in a federal suit seeking to enjoin threatened enforcement,” or under a retaliation provision. Id. Plainly then, the Guidance “govern[s] . . . the eligibility of individuals, entities, or organizations to furnish or receive services or benefits” under the Medicare Act.
HHS‘s argument thus hinges on whether the Guidance “establishes or changes a substantive legal standard”—i.e., alters EMTALA‘s generally applicable mandate to provide stabilizing treatment for emergency medical conditions. HHS claims it does not and argues that the Guidance addresses obligations that EMTALA itself imposes only if two conditions are met: (1) the medical provider believes that a pregnant patient presenting at an emergency department is experiencing an emergency medical condition as defined by EMTALA, and (2) that medical provider concludes that an abortion is the stabilizing treatment necessary.
As discussed at length infra, the Guidance goes beyond EMTALA by mandating
D.
In the least, HHS seeks to narrow the injunction, claiming that the language is overbroad.
(1) The defendants may not enforce the Guidance and Letter‘s interpretation that Texas abortion laws are preempted by EMTALA; and
(2) The defendants may not enforce the Guidance and Letter‘s interpretation of EMTALA—both as to when an abortion is required and EMTALA‘s effect on state laws governing abortion—within the State of Texas or against AAPLOG‘s members and CMDA‘s members.
The injunction is not overbroad. As previously discussed, EMTALA does not mandate medical treatments, let alone abortion care, nor does it preempt Texas law. The injunction squarely enjoins HHS from enforcing the Guidance and Letter regarding these two issues within the State of Texas and against the plaintiff organizations. A plain reading of the injunction language also leaves exceptions under the Texas HLPA. See
VI.
For the foregoing reasons, the injunction is AFFIRMED.
KURT D. ENGELHARDT
UNITED STATES CIRCUIT JUDGE
